Vanderbilt University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.
Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 3 of 9
Local Heat Stress in Autonomic Failure Patients With Supine Hypertension
NCT02417415
A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
NCT02368340
Lymphedema Progression Screening Using MRI
NCT02611557
Isotonic Solution Administration Logistical Testing
NCT02345486
Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH
NCT02631421
Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
NCT02362308
Improving Hospitalizations for Children With ASD
NCT02339935
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
NCT02245230
Scapular and Cervical Neuromuscular Control Deficits in Musicians With and Without Playing Injuries.
NCT02267395
Immune Modulation by Misoprostol
NCT02259309
Water and Sudafed in Autonomic Failure
NCT02149901
Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme
NCT02476565
Comprehensive Communication Intervention for Minimally Verbal Children With Autism
NCT02291172
Tissue Sodium in Pre-hypertensive Patients
NCT02236520
Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence
NCT02215655
Posture Detection for Automated Abdominal Binder
NCT02280369
A Family Depression Prevention Program
NCT02021578
Family Cognitive Behavioral Therapy for Preventing Depression in Children
NCT00183482
SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)
NCT02276534
Nasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery Patients
NCT02219464
A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)
NCT02159079
Comparative Effects of Aspirin and NHP-544C
NCT02189122
Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI
NCT02220023
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
NCT02187445
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
NCT02130687
Phenotypic Specific Communication Intervention for Children With Down Syndrome
NCT02158390
Weight Changes During and After Pregnancy in Women With Gestational Diabetes
NCT02388958
TDAP Safety in Pregnant Women
NCT02209623
Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation
NCT02219906
Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy
NCT02050451
Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis
NCT02024555
Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors
NCT02129712
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit: The FELLOW Study
NCT02051816
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
NCT01992926
Measurement of Pulmonary Transit Time by Echocardiography: Comparison With Cardiac MRI
NCT02088320
Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis
NCT00924547
Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)
NCT02006784
Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression
NCT01896934
Typing Proficiency Following Carpal Tunnel Release
NCT01853969
Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression
NCT01794455
Reliability of an Algorithm to Diagnose Spasticity
NCT01644123
Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis
NCT01739361
King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope
NCT02324465
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
NCT01791465
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
NCT01661764
The Effect of Exercise on Hepatic Glucose Metabolism
NCT01783275
Prevalence of Spasticity in Veterans Living in a Long-term Care Facility
NCT01879449
Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers
NCT01796951
Effect of DPP4 Inhibition on Growth Hormone Secretion
NCT01701973
Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
NCT01764711
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 42 |
| Phase 3 | 10 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Vanderbilt University pipeline
15 recruiting of 430 indexed (3% open); 343 completed (80%).
Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vanderbilt University: open-pipeline peers nationwide
Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 3% open enrollment (± trial volume)
- USDA Grand Forks Human Nutrition Research Center · 4% recruiting · 57 trials
- Medtronic MiniMed · 3% recruiting · 29 trials
- Sandoz · 3% recruiting · 29 trials
- Sonova · 3% recruiting · 29 trials
Related
What to do with this Vanderbilt University page
430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.
- 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Vanderbilt University pipeline card: 430 registered trials from official public datasets.Report a data error.